Obtain baseline eGFR and/or platelet count for all patients with suspected or known renal impairment and/or thrombocytopenia	Yes
Any patient with baseline moderate or worse renal impairment (eGFR <50 mL/min) to be dose adjusted as per BNF/pharmacist guidance	Yes
Prophylactic dose subcutaneous LMWH once daily prescribed until date of clinical/orthopaedic review	Yes
Patients educated regarding s/c injection technique OR district nurse referral for ongoing injections	Yes
Safety net in place regarding bleeding complications	Yes
Written guidance to patient and GP regarding signs of HIT/coagulopathy and advice to consider platelet check in 5 days time if review delayed	Yes